Pharmaceuticals

Single-Cell Omics Market Forecast 2026–2035: How to Leverage Market Growth

February 18, 2026February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the single-cell omics market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Single-Cell Omics Market expected to grow between 2026 and 2030?

The single-cell omics market has seen rapid expansion in recent years. Its size is projected to increase from $2.39 billion in 2025 to $2.78 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 16.3%. This historical growth can be ascribed to several factors, including advancements in next-generation sequencing, rising academic research funding, an increase in cancer research initiatives, the demand for cellular heterogeneity analysis, and improvements in cell isolation technologies.

The single-cell omics market is projected to experience considerable growth over the next few years, with its size expected to reach $5.27 billion by 2030, achieving a compound annual growth rate (CAGR) of 17.4%. This anticipated expansion during the forecast period is fueled by several factors, including the increasing scope of precision medicine programs, the incorporation of AI in omics analysis, rising investments in pharmaceutical R&D, wider adoption in clinical diagnostics, and the development of cost-effective single-cell platforms. Prominent trends for the forecast period involve the growing acceptance of multi-omics approaches, an escalating demand for high-resolution cellular analysis, the broadening application of single-cell methods in oncology research, enhanced use of microfluidics for cell isolation, and the standardization of single-cell analysis workflows.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

Which Drivers Are Influencing Market Acceleration In The Single-Cell Omics Market?

The increasing occurrence of cancer is projected to drive the expansion of the single-cell omics market in the future. Cancer encompasses a range of diseases that can emerge in almost any organ or tissue when abnormal cells multiply uncontrollably, exceeding their normal limits, and either metastasize to other organs or infiltrate adjacent body parts. Single-cell omics data has been extensively utilized for identifying biomarkers crucial for cancer diagnosis, predicting prognosis, and uncovering new therapeutic targets within defined clinical groups. For instance, in May 2024, the National Institutes of Health, a US-based government agency, reported that roughly 18.1 million individuals in the United States were living as cancer survivors as of January 2022. This figure is anticipated to increase to 22.5 million by 2032. Consequently, the growing prevalence of cancer is fueling the growth of the single-cell omics market.

What Leading Segments Are Studied In The Single-Cell Omics Market?

The single-cell omics market covered in this report is segmented –

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing

3) By Application: Oncology, Cell Biology, Neurology, Immunology

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits

2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits

3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits

4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits

What Industry Trends Are Transforming The Single-Cell Omics Market?

Major companies in the single-cell omics market are prioritizing the development of sophisticated kits, such as sequencing kits, for single-cell applications to bolster their market revenues. Sequencing kits are defined as pre-packaged sets of reagents and materials intended for genetic sequencing procedures, thereby simplifying laboratory workflows. For instance, in February 2023, Singular Genomics Systems, Inc., a US-based company leveraging novel next-generation sequencing (NGS), introduced the Max Read Kits specifically for single-cell sequencing on its G4 Sequencing Platform. The Max Read Kits are designed to be compatible with popular 10x Genomics assays and offer the flexibility to sequence 4 to 16 samples per run. These kits deliver 800 million reads per flow cell with an 80% to 90% Q30 quality. Additionally, Singular Genomics has improved the quality specifications of the G4 Sequencing Platform’s F2 and F3 flow cells, achieving up to 1.8 billion reads per run on the F3 flow cells for select applications.

Which Major Firms Are Strengthening Their Position In The Single-Cell Omics Market?

Major companies operating in the single-cell omics market are Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Thermo Fisher Scientific Inc, Agilent Technologies Inc, Sartorius AG, Illumina Inc, Bio Rad Laboratories Inc, Qiagen NV, Tecan Group Ltd, BGI Genomics Co Ltd, 10x Genomics Inc, Takara Bio Inc, NanoString Technologies Inc, Vizgen, Deepcell, Mission Bio Inc, Standard BioTools Inc, CYTENA GmbH, Single Cell Discoveries

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

Which Region Shows The Strongest Potential For Future Expansion In The Single-Cell Omics Market?

North America was the largest region in the single-cell omics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Single-Cell Omics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12379&type=smp

Browse Through More Reports Similar to the Global Single-Cell Omics Market 2026, By The Business Research Company

Single Cell Omics Market Report 2026

https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

Single Cell Analysis Market 2026

https://www.thebusinessresearchcompany.com/report/single-cell-analysis-market

Single Cell Genome Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/single-cell-genome-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795